Noboru Nakaigawa

10PUBLICATIONS
12CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 26, 2025
Short-term outcomes of triplet therapy in metastatic hormone-sensitive prostate cancer in older adults: a retrospective, single-center real-world cohort study.

Kimitsugu Usui, Hayato Kubo, Takahiro Matsumoto

|Nov 26, 2024
Combining Transarterial Embolization and Percutaneous Cryoablation for Early-Stage Renal Cell Carcinoma: Embolization Materials and Impacts of Tumor Size.

Miki Terauchi, Tsuneo Yamashiro, Shungo Sawamura

|Jun 16, 2020
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma.

Go Noguchi, Noboru Nakaigawa, Susumu Umemoto

|Apr 04, 2019
Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab.

Tadashi Tabei, Noboru Nakaigawa, Tomohiro Kaneta

|Nov 08, 2018
PD-1 and PD-L1 are more highly expressed in high-grade bladder cancer than in low-grade cases: PD-L1 might function as a mediator of stage progression in bladder cancer.

Takashi Kawahara, Yukari Ishiguro, Shinji Ohtake

|Jul 07, 2018
Renal Cell Carcinoma in a Horseshoe Kidney Treated with Laparoscopic Partial Nephrectomy.

Shinji Ohtake, Takashi Kawahara, Go Noguchi

Pageof 2

Frequent Collaborators

2 joint publications

Takashi Kawahara

2 joint publications

Hiroji Uemura

1 joint publications

Ryo Kasahara

1 joint publications

Tadashi Tabei